 The FDA has granted Fast Track Designation to Aquestive Therapeutics Incs NASDAQ: AQST AQST-109 for allergic reactions. AQST-109 is an orally delivered epinephrine-based product candidate for the emergency treatment of allergic reactions, including anaphylaxis. 